254 related articles for article (PubMed ID: 20692307)
1. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
2. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
[TBL] [Abstract][Full Text] [Related]
3. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
[TBL] [Abstract][Full Text] [Related]
4. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
[TBL] [Abstract][Full Text] [Related]
5. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
7. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
[TBL] [Abstract][Full Text] [Related]
8. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
9. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles.
Kim YC; Quan FS; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Infect Dis; 2010 Jan; 201(2):190-8. PubMed ID: 20017632
[TBL] [Abstract][Full Text] [Related]
10. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.
Kim YC; Yoo DG; Compans RW; Kang SM; Prausnitz MR
J Control Release; 2013 Dec; 172(2):579-88. PubMed ID: 23643528
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
12. Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice.
Quan FS; Vunnava A; Compans RW; Kang SM
PLoS One; 2010 Feb; 5(2):e9161. PubMed ID: 20161790
[TBL] [Abstract][Full Text] [Related]
13. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
[TBL] [Abstract][Full Text] [Related]
14. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
Vrdoljak A; Allen EA; Ferrara F; Temperton NJ; Crean AM; Moore AC
J Control Release; 2016 Mar; 225():192-204. PubMed ID: 26774221
[TBL] [Abstract][Full Text] [Related]
15. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
16. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.
Koutsonanos DG; Esser ES; McMaster SR; Kalluri P; Lee JW; Prausnitz MR; Skountzou I; Denning TL; Kohlmeier JE; Compans RW
Vaccine; 2015 Sep; 33(37):4675-82. PubMed ID: 25744228
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
Levin Y; Kochba E; Kenney R
Vaccine; 2014 Jul; 32(34):4249-52. PubMed ID: 24930715
[TBL] [Abstract][Full Text] [Related]
18. Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Jacob J; Prausnitz MR; Compans RW; Skountzou I
J Infect Dis; 2011 Aug; 204(4):582-91. PubMed ID: 21685355
[TBL] [Abstract][Full Text] [Related]
19. Transdermal influenza immunization with vaccine-coated microneedle arrays.
Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
[TBL] [Abstract][Full Text] [Related]
20. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
